DocGo Inc. Payments to Acquire Equity Method Investments
DocGo Inc. (DCGO) reported Payments to Acquire Equity Method Investments of $4.78 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireEquityMethodInvestments · last filed 2026-03-16
- DocGo Inc. payments to acquire equity method investments for the quarter ending 2025-12-31 was $0.00.
- DocGo Inc. payments to acquire equity method investments for the quarter ending 2025-09-30 was $4.78K, a 97.05% decline year-over-year.
- DocGo Inc. payments to acquire equity method investments for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- DocGo Inc. payments to acquire equity method investments for the quarter ending 2024-09-30 was $161.96K, a 7.61% increase year-over-year.
- DocGo Inc. payments to acquire equity method investments for fiscal 2025 was $4.78K, a 98.46% decline from fiscal 2024.
- DocGo Inc. payments to acquire equity method investments for fiscal 2024 was $310.45K, a 3.85% increase from fiscal 2023.
- DocGo Inc. payments to acquire equity method investments for fiscal 2023 was $298.93K.
- DocGo Inc. payments to acquire equity method investments for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Payments to Acquire Equity Method Investments 3 month | Payments to Acquire Equity Method Investments 6 month | Payments to Acquire Equity Method Investments 9 month | Payments to Acquire Equity Method Investments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $4.78K derived: sum of 2 quarters · filed 2026-03-16 | $4.78K 10-K · filed 2026-03-16 | |
| 2025-09-30 | $4.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $4.78K 10-Q · filed 2025-11-10 | ||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $161.96K derived: sum of 2 quarters · filed 2026-03-16 | $310.45K 10-K · filed 2026-03-16 | |
| 2024-09-30 | $161.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $310.45K 10-Q · filed 2025-11-10 | ||
| 2024-06-30 | $148.49K 10-Q · filed 2025-08-07 | |||
| 2023-12-31 | $148.42K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $298.93K derived: sum of 2 quarters · filed 2026-03-16 | $298.93K 10-K · filed 2026-03-16 | |
| 2023-09-30 | $150.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $150.51K 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-07 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-06 | |||
| 2021-12-31 | $655.88K 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |